
Clorox (CLX) is projected to report a significant year-over-year decline for the quarter ending September 2025, with consensus estimates anticipating EPS of $0.79 (down 57.5%) on $1.39 billion in revenue (down 21.2%). Analyst sentiment has become more bearish, evidenced by a 1.3% downward revision in EPS estimates over the past 30 days, a negative Zacks Earnings ESP of -7.11%, and a Zacks Rank of #4. This combination suggests Clorox is not a strong candidate for an earnings beat, despite having surpassed estimates in three of the last four quarters, indicating potential stock volatility around its upcoming earnings release.
Clorox (CLX) is projected to report a substantial year-over-year decline for the quarter ending September 2025, with consensus estimates forecasting earnings per share (EPS) of $0.79, a 57.5% decrease, on revenues of $1.39 billion, down 21.2%. This widely-known consensus outlook highlights significant operational headwinds for the consumer products manufacturer. Analyst sentiment has recently deteriorated, reflected by a 1.3% downward revision in the consensus EPS estimate over the last 30 days. The company's Zacks Earnings ESP of -7.11%, indicating the Most Accurate Estimate is below consensus, combined with a Zacks Rank #4 (Sell), suggests a low probability of an earnings beat based on Zacks' predictive model. While Clorox has historically beaten EPS estimates in three of the last four quarters, including a 28.13% surprise in the prior quarter, the current negative Earnings ESP and Zacks Rank #4 make it difficult to confidently predict a positive surprise for the upcoming report. This divergence between historical performance and current predictive signals warrants investor caution.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly negative
Sentiment Score
-0.70
Ticker Sentiment